Skip to main content

Table 1 The establishment of subcutaneous cervical cancer—PDX* models

From: Establishment and genetically characterization of patient-derived xenograft models of cervical cancer

PDX models Failure (%) Success (%) Latency time (days)# Mortalitya (%)
F1 engraftment results 63 (69.23) 28 (30.77) 87.00 (77.25,104.00) 6 (21.43)
F2 engraftment results 17 (31.48) 37 (68.52) 48.00 (40.00,60.50) 5 (13.51)
F3 engraftment results 7 (12.07) 51 (87.93) 38.00 (29.00,46.00) 5 (9.80)
  1. Data are presented as n (%) or median (P25, P75)
  2. *Patient - derived xenograft (PDX)
  3. #The time interval from engraftment to the presence of palpable tumor was defined as the latency time
  4. aThe mortality of mice among the successful cervical cancer engrafted mice